Rasagiline effect on bladder disturbances in early mild Parkinson's disease patients

Parkinsonism and Related Disorders

Volumn 20, Issue 8, 2014, Pages 931-932

  Brusa, L ^a   Musco, S ^b   Bernardi, G ^b,c   Iani, C ^a   Pierantozzi, M ^b,c   Stanzione, P ^b,c   Stefani, A ^b,c   Finazzi Agro', E ^b,c  

^a S Eugenio Hospital   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Bladder; Dopamine; Parkinson; Rasagiline

Indexed keywords

PRAMIPEXOLE; RASAGILINE; ROPINIROLE; ROTIGOTINE; ANTIPARKINSON AGENT; INDAN DERIVATIVE;

AGED; BLADDER CAPACITY; BLADDER DYSFUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG DOSE REDUCTION; FEMALE; HOEHN AND YAHR SCORE; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; LETTER; LOWER URINARY TRACT SYMPTOM; MALE; MICTURITION; MORNING DOSAGE; PARKINSON DISEASE; POST HOC ANALYSIS; PRIORITY JOURNAL; QUESTIONNAIRE; RANK SUM TEST; RATING SCALE; RESIDUAL VOLUME; SCORING SYSTEM; TREATMENT DURATION; TREND STUDY; UNIFIED PARKINSON DISEASE RATING SCALE; URODYNAMICS; BLADDER; CLINICAL TRIAL; DRUG EFFECTS; MIDDLE AGED;

AGED; ANTIPARKINSON AGENTS; FEMALE; HUMANS; INDANS; MALE; MIDDLE AGED; PARKINSON DISEASE; URINARY BLADDER; URODYNAMICS;

EID: 84905237984     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2014.04.020     Document Type: Letter

References (5)

1. Fowler C.J., Griffiths D.J. A decade of functional brain imaging applied to bladder control. Neurourol Urodyn 2010, 29:49-55.
2. Winge K., Werdelin L.M., Nielsen K.K., Stimpel H. Effects of dopaminergic treatment on bladder function in Parkinson's disease. Neurourol Urodyn 2004, 23(7):689-696.
3. Brusa L., Petta F., Pisani A., Moschella V., Iani C., Stanzione P., et al. Acute vs chronic effects of l-dopa on bladder function in patients with mild Parkinson disease. Neurology 2007, 68(18):1455-1459.
4. Lamensdorf I., Youdim M.B., Finberg J. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum invivo. J Neurochem 1996, 67:1532-1539.
5. Cannon D.M., Klaver J.M., Peck S.A., Rallis-Voak D., Erickson K., Drevets W. Dopamine type I receptors binding in major depressive disorder assessed using positron emission tomography and 11CNNC-112. Neuropsychopharmacology 2009, 34:1277-1287.